We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Europe Approves Once-Daily HIV Combo Drug Rezolsta
Europe Approves Once-Daily HIV Combo Drug Rezolsta
November 26, 2014
The European Commission has approved Janssen’s HIV combination drug Rezolsta, which combines the company’s protease inhibitor Prezista and Gilead Sciences’ pharmacokinetic enhancer Tybost.